Filing Details
- Accession Number:
- 0001165527-10-000600
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-18 13:00:00
- Reporting Period:
- 2010-07-15
- Filing Date:
- 2010-08-18
- Accepted Time:
- 2010-08-18 18:46:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1424860 | Enox Biopharma Inc | N/A | Surgical & Medical Instruments & Apparatus (3841) | 260477124 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1454396 | Itamar David | 13 Ahuza St. Pardes Hana L3 37075 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-07-15 | 201,122 | $0.30 | 500,483 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2010-08-12 | 25,000 | $2.00 | 525,483 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Commom Stock | Warrant | Acquisiton | 2010-08-12 | 12,500 | $0.00 | 12,500 | $4.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
12,500 | 2010-08-12 | 2012-08-12 | No | 4 | P | Direct |
Footnotes
- Reporting Person disclaims beneficial ownership of shares owned by his spouse, Hadas David.
- Purchase agreement includes a one year adjusting pre-emption provision to increase number of shares of holder upon payment of par value, at Reporting Person's election if Company sells shares at less than purchase price.
- Exercise price subject to downward formula adjustment if Company sells or commits to sell shares at less than $2.00 during the one year after issuance of Warrant.
- Exercise period subject to extension equal to expiration date of any different class of warrants sold by company during the one year after issuance of Warrant.